Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part B - Behavioral results

BACKGROUND: This study investigated the effects of oral dimercapto succinic acid (DMSA) therapy on the behavioural symptoms of children with autism spectrum disorders (ASD) ages 3-8 years. METHODS: Phase 1 involved 65 children with ASD who received one round of DMSA (3 days). Participants who had hi...

Descripción completa

Detalles Bibliográficos
Autores principales: Adams, James B, Baral, Matthew, Geis, Elizabeth, Mitchell, Jessica, Ingram, Julie, Hensley, Andrea, Zappia, Irene, Newmark, Sanford, Gehn, Eva, Rubin, Robert A, Mitchell, Ken, Bradstreet, Jeff, El-Dahr, Jane
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770991/
https://www.ncbi.nlm.nih.gov/pubmed/19852790
http://dx.doi.org/10.1186/1472-6904-9-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770991/
https://www.ncbi.nlm.nih.gov/pubmed/19852790
http://dx.doi.org/10.1186/1472-6904-9-17

Ejemplares similares